DMLC motion tracking of moving targets for intensity modulated arc therapy treatment: a feasibility study
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
DMLC motion tracking of moving targets for intensity modulated arc therapy treatment : a feasibility study. / Zimmerman, Jens; Korreman, Stine; Persson, Gitte; Cattell, Herb; Svatos, Michelle; Sawant, Amit; Venkat, Raghu; Carlson, David; Keall, Paul.
In: Acta Oncologica, Vol. 48, No. 2, 2009, p. 245-50.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - DMLC motion tracking of moving targets for intensity modulated arc therapy treatment
T2 - a feasibility study
AU - Zimmerman, Jens
AU - Korreman, Stine
AU - Persson, Gitte
AU - Cattell, Herb
AU - Svatos, Michelle
AU - Sawant, Amit
AU - Venkat, Raghu
AU - Carlson, David
AU - Keall, Paul
PY - 2009
Y1 - 2009
N2 - PURPOSE: Intensity modulated arc therapy offers great advantages with the capability of delivering a fast and highly conformal treatment. However, moving targets represent a major challenge. By monitoring a moving target it is possible to make the beam follow the motion, shaped by a Dynamic MLC (DMLC). The aim of this work was to evaluate the dose delivered to moving targets using the RapidArc (Varian Medical Systems, Inc.) technology with and without a DMLC tracking algorithm.MATERIAL AND METHODS: A Varian Clinac iX was equipped with a preclinical RapidArc and a 3D DMLC tracking application. A motion platform was placed on the couch, with the detectors on top: a PTW seven29 and a Scandidos Delta4. One lung plan and one prostate plan were delivered. Motion was monitored using a Real-time Position Management (RPM) system. Reference measurements were performed for both plans with both detectors at state (0) "static, no tracking". Comparing measurements were made at state (1) "motion, no tracking" and state (2) "motion, tracking".RESULTS: Gamma analysis showed a significant improvement from measurements of state (1) to measurements of state (2) compared to the state (0) measurements: Lung plan; from 87 to 97% pass. Prostate plan; from 81 to 88% pass. Sub-beam information gave a much reduced pattern of periodically spatial deviating dose points for state (2) than for state (1). Iso-dose curve comparisons showed a slightly better agreement between state (0) and state (2) than between state (0) and state (1).CONCLUSIONS: DMLC tracking together with RapidArc make a feasible combination and is capable of improving the dose distribution delivered to a moving target. It seems to be of importance to minimize noise influencing the tracking, to gain the full benefit from the application.
AB - PURPOSE: Intensity modulated arc therapy offers great advantages with the capability of delivering a fast and highly conformal treatment. However, moving targets represent a major challenge. By monitoring a moving target it is possible to make the beam follow the motion, shaped by a Dynamic MLC (DMLC). The aim of this work was to evaluate the dose delivered to moving targets using the RapidArc (Varian Medical Systems, Inc.) technology with and without a DMLC tracking algorithm.MATERIAL AND METHODS: A Varian Clinac iX was equipped with a preclinical RapidArc and a 3D DMLC tracking application. A motion platform was placed on the couch, with the detectors on top: a PTW seven29 and a Scandidos Delta4. One lung plan and one prostate plan were delivered. Motion was monitored using a Real-time Position Management (RPM) system. Reference measurements were performed for both plans with both detectors at state (0) "static, no tracking". Comparing measurements were made at state (1) "motion, no tracking" and state (2) "motion, tracking".RESULTS: Gamma analysis showed a significant improvement from measurements of state (1) to measurements of state (2) compared to the state (0) measurements: Lung plan; from 87 to 97% pass. Prostate plan; from 81 to 88% pass. Sub-beam information gave a much reduced pattern of periodically spatial deviating dose points for state (2) than for state (1). Iso-dose curve comparisons showed a slightly better agreement between state (0) and state (2) than between state (0) and state (1).CONCLUSIONS: DMLC tracking together with RapidArc make a feasible combination and is capable of improving the dose distribution delivered to a moving target. It seems to be of importance to minimize noise influencing the tracking, to gain the full benefit from the application.
KW - Algorithms
KW - Feasibility Studies
KW - Humans
KW - Lung Neoplasms/radiotherapy
KW - Male
KW - Movement/physiology
KW - Particle Accelerators
KW - Phantoms, Imaging
KW - Prostatic Neoplasms/radiotherapy
KW - Radiotherapy Dosage
KW - Radiotherapy, Intensity-Modulated/instrumentation
KW - Respiration
KW - Scattering, Radiation
U2 - 10.1080/02841860802266722
DO - 10.1080/02841860802266722
M3 - Journal article
C2 - 18720056
VL - 48
SP - 245
EP - 250
JO - Acta Oncologica
JF - Acta Oncologica
SN - 1100-1704
IS - 2
ER -
ID: 209063240